Promoter and Cofactor Requirements for SERM-ER Activity
Abstract
The mechanism by which Estrogen Receptor regulates transcription is poorly understood. We aimed to identify, in an unbiased manner, DNA elements and proteins that augment or inhibit ER activity in vivo. We used a combination of Chromatin Immunoprecipitation (Chip) with various novel approaches to identify contributing factors. We initially mapped ER binding using Chip in combination with tiling microarrays that cover the entire non-repetitive sequence of chromosomes 21 and 22. This study resulted in several novel conclusions, including the fact that ER rarely binds to promoter regions but uses distal enhancer and that these distal enhancers are defined by the presence of a Forkhead protein, namely FoxA1. We also showed that FoxA1 is essential for ER binding to the chromatin and for subsequent gene transcription. More recently, we have extended on these findings and have mapped all in vivo ER and RNA Polymerase II binding sites in a breast cancer cell line. We are currently mining this large dataset, but have already found a number of novel ER associated proteins that appear to be essential for ER-mediated transcription.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2006
- Accession Number
- ADA452289
Entities
People
- Jason S. Carroll
Organizations
- Dana–Farber Cancer Institute